Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients
Crossref DOI link: https://doi.org/10.1007/s40291-017-0307-7
Published Online: 2017-11-01
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdelmonsif, Doaa Ali http://orcid.org/0000-0002-6859-1156
Sultan, Ahmed S.
El-Hadidy, Wessam F.
Abdallah, Dina Mohamed
License valid from 2017-11-01